Please enable JavaScript
Powered by Benchmark International Archives - Page 857 of 1994 - Matribhumi Samachar English
Monday, February 16 2026 | 11:03:37 AM
Home / International (page 857)

International

The Canadian Chrome Company Announces …

Toronto, Ontario–(Newsfile Corp. – August 28, 2025) – The Canadian Chrome Company Inc. (CSE: CACR) (CSE: CACR.A) (formerly KWG Resources Inc.) (“CCC“, “KWG” or the “Company“) is pleased to announce that it has transferred 299 mineral claims within its utility corridor, to The Gitchiziibii Company in Trust for Matawa Management as Trustee …

Read More »

Luxxfolio Files Preliminary $100 Million Base Shelf Prospectus

Vancouver, British Columbia–(Newsfile Corp. – August 28, 2025) – Luxxfolio Holdings Inc. (CSE: LUXX) (OTCQB: LUXFF) (FSE: LUH0) (“Luxxfolio” or the “Company”), a leading Litecoin treasury and infrastructure company, is pleased to announce that it has filed a preliminary short form base shelf prospectus (the “Preliminary Shelf Prospectus”) with the …

Read More »

Vital Energy Announces Amendments to Existing Credit Facility

Calgary, Alberta–(Newsfile Corp. – August 28, 2025) – Vital Energy Inc. (TSXV: VUX) (the “Corporation”) announces that, further to its December 5, 2023, April 3, 2024 and August 28, 2024 news releases, it has amended the terms of its existing credit facility (the “Credit Facility“) to extend the maturity date from August …

Read More »

More Than Half of Marketers Use AI in Their Strategies – DesignRush Selects the Top Digital Marketing Agencies Driving Smarter Growth

DesignRush has shortlisted the leading digital marketing agencies as AI adoption reshapes the industry. New York, New York–(Newsfile Corp. – August 28, 2025) – A report from Marketing Week indicates that 59% of marketers are utilizing AI tools to enhance their campaigns, while the global AI-in-marketing market is projected to reach nearly …

Read More »

Hemostemix Announces Financing Plans for VesCell(TM) Treatment

Calgary, Alberta–(Newsfile Corp. – August 28, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and total body …

Read More »